AMEND Presents at ENS@T Scientific Meeting

Thank you to everyone who completed our phaeochromocytoma patient experience survey, the results of which Jo presented at the ENS@T meeting in Porto (and which will be shared on social media for NET Cancer Day in November). This was AMEND’s first time at this scientific meeting and we hope it’s not the last. The amount of collaborative/individual European research into adrenal tumours and cancer is phenomenal and instills a huge sense of hope for the future of treatment of affected patients. It was an honour for AMEND to be even a small a part of the meeting.
.